Qscription Technologies Appoints Dr. Kimberly Beavers as Founding Clinical Advisor

WEST BEND, Wis. - Rezul -- Qscription Technologies Inc., a US market-entry consulting firm for medical imaging and healthcare AI companies, today announced the appointment of Kimberly Beavers, MD as Founding Clinical Advisor.

Dr. Beavers is a fellowship-trained, board-certified breast imaging radiologist and Clinical Assistant Professor at NYU Langone Health. Her clinical background spans academic and private practice, giving her a broad view of breast imaging across diverse practice settings.

Deeply engaged in organized radiology and health policy, Dr. Beavers serves as Secretary of the Florida Radiological Society, where she also chairs the Social Media Committee and the Delegation to the Florida Medical Association. She is a Board Member of and the inaugural Teleradiology Subcommittee Chair for RADPAC, a member of the American College of Radiology's Commission on Government Relations, a content developer for the ACR's national Advocacy Curriculum, and a contributor to examination development for the American Board of Radiology.

More on Rezul News

• Indian Shores STR Condo Sales Rise 50% Year to Date as Median Price Falls 7% in 2026
• FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
• Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
• Land For Sale Lake Conroe TX – Lots & Acreage
• Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany

"Breast imaging is entering a remarkable era, and AI will only fulfill its promise if it is evaluated rigorously and adopted in ways that genuinely serve patients and radiologists. I am delighted to join Qscription as Founding Clinical Advisor to help make that happen.", said Dr. Beavers.

"Dr. Beavers brings something rare: the clinical authority of a practicing breast imager and a national voice in the policy conversations that decide how innovation reaches patients," said Dr. Nisha, President and Chairman of the Board of Qscription Technologies. "Her guidance will sharpen how we evaluate breast imaging AI for our partners and, more importantly, how responsibly it gets adopted."

As Founding Clinical Advisor, Dr. Beavers will support clinical evaluation and validation of breast imaging AI (CADe/CADx), advise on workflow and adoption, and contribute to pilot programs, educational initiatives, and clinical strategy across Qscription's partner portfolio.

About Qscription Technologies Qscription Technologies Inc. is a US market-entry consulting firm that helps international medical imaging and healthcare AI companies establish and grow in the United States, from regulatory and reimbursement strategy through enterprise integration and commercial adoption, guided by its Decipher(TM) framework. Learn more at https://qscription.tech.